NATURECELL CO.,LTD.
Manufactures food, beverages, and cosmetics; researches stem cell therapies.
007390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7007390008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 국회대로76길 10 5층, 서울특별시
- Website:
- http://en.naturecell.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-10 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2023-03-10 00:00 |
의결권대리행사권유참고서류
|
Korean | 240.3 KB | ||
| 2023-03-09 00:00 |
[기재정정]투자판단관련주요경영사항(대표이사 3심(상고심) 선고 결과(무죄 확정))
|
Korean | 12.2 KB | ||
| 2023-03-09 00:00 |
최대주주변경을수반하는주식담보제공계약체결
|
Korean | 23.1 KB | ||
| 2023-02-14 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 119.5 KB | ||
| 2023-02-13 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 13.3 KB | ||
| 2023-02-13 00:00 |
주주총회소집결의
|
Korean | 11.6 KB | ||
| 2023-02-08 00:00 |
최대주주변경
|
Korean | 36.8 KB | ||
| 2023-01-31 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 128.6 KB | ||
| 2023-01-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.0 KB | ||
| 2023-01-03 00:00 |
[기재정정]투자판단관련주요경영사항(동종지방유래 줄기세포를 이용한 퇴행성관절염 줄기세포치료제(아조스템) 개발을 위한 기술도입계약 해지)
|
Korean | 12.6 KB | ||
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2022-12-13 00:00 |
투자판단관련주요경영사항(동종지방유래 줄기세포를 이용한 퇴행성관절염 줄기세포치료제(아조스템) 개발을 위한 기술도입계약 해지)
|
Korean | 7.7 KB | ||
| 2022-11-15 00:00 |
[기재정정]분기보고서 (2022.09)
|
Korean | 1.5 MB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all NATURECELL CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NATURECELL CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NATURECELL CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
